Tradr 2X Long ALAB Daily ETF (LABX) Price & Chart

The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors need to know, as compiled by

RBC Capital lowered the firm’s price target on Astera Labs (ALAB) to $400 from $500 and keeps an Outperform rating on the shares. The company reported another strong beat and

TD Cowen analyst Sean O’Loughlin lowered the firm’s price target on Astera Labs (ALAB) to $225 from $300 and keeps a Hold rating on the shares. The firm said Scorpio

UBS analyst Timothy Arcuri has maintained their neutral stance on ALAB stock, giving a Hold rating today. Timothy Arcuri’s rating is based on a combination of strong operating results and

Roth Capital lowered the firm’s price target on Astera Labs (ALAB) to $350 from $450 and keeps a Buy rating on the shares. The company reported another solid revenue beat

Morgan Stanley raised the firm’s price target on Astera Labs (ALAB) to $389 from $382 and keeps an Overweight rating on the shares. Published first on TheFly – the ultimate

Susquehanna lowered the firm’s price target on Astera Labs (ALAB) to $258 from $310 and keeps a Neutral rating on the shares. The firm updated its estimates following Q3 results.

UBS lowered the firm’s price target on Astera Labs (ALAB) to $290 from $300 and keeps a Neutral rating on the shares. Astera Labs delivered strong results and above-consensus guidance,

Northland upgraded Astera Labs (ALAB) to Outperform from Market Perform with a price target of $315, down from $350. The company reported a strong quarter and raised its guidance, the